M Verstraete. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Ancrod/therapeutic useAnimalsArterial Occlusive Diseases/drug therapyAspirin/therapeutic useBatroxobin/therapeutic useClinical Trials as TopicFibrinolysin/therapeutic useHematologyHeparin/therapeutic useHumansInfant, NewbornMyocardial Infarction/drug therapyPlasminogen/therapeutic usePulmonary Embolism/drug therapyRegistriesResearchRespiratory Distress Syndrome, Newborn/complicationsStreptokinase/therapeutic useSulfinpyrazone/therapeutic useSwineThrombophlebitis/drug therapyUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » PlasminogenHeparinStreptokinaseAncrodBatroxobinFibrinolysinUrokinase-Type Plasminogen ActivatorAspirinSulfinpyrazone
Year: 1975 PMID: 125464
Source DB: PubMed Journal: Thromb Diath Haemorrh ISSN: 0340-5338